MetLife Investment Management’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$109K	Buy	31,553 +243	+0.8%	+$836	﹤0.01%	2503
2025 Q1	$66.7K	Buy	31,310 +9,082	+41%	+$19.3K	﹤0.01%	2658
2024 Q4	$70.9K	Sell	22,228 -8,937	-29%	-$28.5K	﹤0.01%	2708
2024 Q3	$416K	Buy	31,165 +19,137	+159%	+$255K	﹤0.01%	1880
2024 Q2	$120K	Buy	+12,028	New	+$120K	﹤0.01%	2513